CN104788419A - 手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用 - Google Patents
手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用 Download PDFInfo
- Publication number
- CN104788419A CN104788419A CN201410844333.2A CN201410844333A CN104788419A CN 104788419 A CN104788419 A CN 104788419A CN 201410844333 A CN201410844333 A CN 201410844333A CN 104788419 A CN104788419 A CN 104788419A
- Authority
- CN
- China
- Prior art keywords
- chirality
- dimethyl
- preparation
- dioxolanes
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- -1 (2, 2-dimethyl-1, 3-dioxolane-4-yl) hydroxymethanesulfonate Chemical compound 0.000 title claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 50
- PIGNSJBCTZRHTO-UHFFFAOYSA-N CC([CH2-])=O.OCC(O)C=O Chemical compound CC([CH2-])=O.OCC(O)C=O PIGNSJBCTZRHTO-UHFFFAOYSA-N 0.000 claims abstract description 41
- 238000003756 stirring Methods 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000007239 Wittig reaction Methods 0.000 claims abstract description 21
- SUPUVLWGKPVHBQ-UHFFFAOYSA-M lithium sulfite Chemical compound [Li+].OS([O-])=O SUPUVLWGKPVHBQ-UHFFFAOYSA-M 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 13
- LPHFLPKXBKBHRW-UHFFFAOYSA-L magnesium;hydrogen sulfite Chemical compound [Mg+2].OS([O-])=O.OS([O-])=O LPHFLPKXBKBHRW-UHFFFAOYSA-L 0.000 claims abstract description 8
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 claims abstract description 8
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 claims abstract description 8
- LVGQIQHJMRUCRM-UHFFFAOYSA-L calcium bisulfite Chemical compound [Ca+2].OS([O-])=O.OS([O-])=O LVGQIQHJMRUCRM-UHFFFAOYSA-L 0.000 claims abstract description 7
- 235000010260 calcium hydrogen sulphite Nutrition 0.000 claims abstract description 7
- DETXZQGDWUJKMO-UHFFFAOYSA-N 2-hydroxymethanesulfonic acid Chemical class OCS(O)(=O)=O DETXZQGDWUJKMO-UHFFFAOYSA-N 0.000 claims description 48
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 44
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 32
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- 150000001299 aldehydes Chemical class 0.000 claims description 29
- 235000009508 confectionery Nutrition 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 16
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 16
- 235000011152 sodium sulphate Nutrition 0.000 claims description 16
- 238000002390 rotary evaporation Methods 0.000 claims description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- FDSGHYHRLSWSLQ-UHFFFAOYSA-N dichloromethane;propan-2-one Chemical compound ClCCl.CC(C)=O FDSGHYHRLSWSLQ-UHFFFAOYSA-N 0.000 claims description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 10
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 7
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 7
- 235000011151 potassium sulphates Nutrition 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 238000003786 synthesis reaction Methods 0.000 claims description 6
- 239000000376 reactant Substances 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 3
- 229910021645 metal ion Inorganic materials 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 abstract description 5
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229940099427 potassium bisulfite Drugs 0.000 abstract 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 abstract 1
- 229940043349 potassium metabisulfite Drugs 0.000 abstract 1
- 235000010263 potassium metabisulphite Nutrition 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 34
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 21
- PIGNSJBCTZRHTO-DFWYDOINSA-N CC([CH2-])=O.OC[C@@H](O)C=O Chemical compound CC([CH2-])=O.OC[C@@H](O)C=O PIGNSJBCTZRHTO-DFWYDOINSA-N 0.000 description 11
- YSGPYVWACGYQDJ-UHFFFAOYSA-N D-glyceraldehyde acetonide Natural products CC1(C)OCC(C=O)O1 YSGPYVWACGYQDJ-UHFFFAOYSA-N 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- FOVKMADVWHEINA-UHFFFAOYSA-N hydroxymethanesulfonic acid;potassium Chemical compound [K].OCS(O)(=O)=O FOVKMADVWHEINA-UHFFFAOYSA-N 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 230000009257 reactivity Effects 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 150000001336 alkenes Chemical class 0.000 description 4
- 230000001590 oxidative effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- ICCISPGEIAECGB-UHFFFAOYSA-N [Li].OCS(=O)(=O)O Chemical compound [Li].OCS(=O)(=O)O ICCISPGEIAECGB-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- IFEOPCSQTDOBQW-UHFFFAOYSA-N ethyl 2-[ethylidene(diphenyl)-$l^{5}-phosphanyl]benzoate Chemical compound CCOC(=O)C1=CC=CC=C1P(=CC)(C=1C=CC=CC=1)C1=CC=CC=C1 IFEOPCSQTDOBQW-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229960003975 potassium Drugs 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- YSGPYVWACGYQDJ-YFKPBYRVSA-N CC(C)(OC1)O[C@H]1C=O Chemical compound CC(C)(OC1)O[C@H]1C=O YSGPYVWACGYQDJ-YFKPBYRVSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- GRWZHXKQBITJKP-UHFFFAOYSA-N dithionous acid Chemical compound OS(=O)S(O)=O GRWZHXKQBITJKP-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- PTVWPYVOOKLBCG-UHFFFAOYSA-N 3-(4-phenyl-1-piperazinyl)propane-1,2-diol Chemical compound C1CN(CC(O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-UHFFFAOYSA-N 0.000 description 1
- RTSRVAYOSGAUPB-CNZKWPKMSA-N CC(C)(OC1)O[C@H]1C(O)S(O)(=O)=O Chemical compound CC(C)(OC1)O[C@H]1C(O)S(O)(=O)=O RTSRVAYOSGAUPB-CNZKWPKMSA-N 0.000 description 1
- 0 CC(C)(OC1)O[C@]1C(*)O Chemical compound CC(C)(OC1)O[C@]1C(*)O 0.000 description 1
- LXIFVMSOURMTLU-UHFFFAOYSA-N CC(C1OC(N)(N)OC1)N=O Chemical compound CC(C1OC(N)(N)OC1)N=O LXIFVMSOURMTLU-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- OISYTMCVNPMUAG-UHFFFAOYSA-N [Mg].C(O)S(=O)(=O)O Chemical compound [Mg].C(O)S(=O)(=O)O OISYTMCVNPMUAG-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960004722 dropropizine Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- WMDSZGFJQKSLLH-RBBKRZOGSA-N landiolol Chemical compound O1C(C)(C)OC[C@H]1COC(=O)CCC(C=C1)=CC=C1OC[C@@H](O)CNCCNC(=O)N1CCOCC1 WMDSZGFJQKSLLH-RBBKRZOGSA-N 0.000 description 1
- 229950005241 landiolol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical class [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/20—Free hydroxyl or mercaptan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844333.2A CN104788419B (zh) | 2014-12-30 | 2014-12-30 | 手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410844333.2A CN104788419B (zh) | 2014-12-30 | 2014-12-30 | 手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104788419A true CN104788419A (zh) | 2015-07-22 |
CN104788419B CN104788419B (zh) | 2018-12-21 |
Family
ID=53553658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410844333.2A Active CN104788419B (zh) | 2014-12-30 | 2014-12-30 | 手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104788419B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108069933A (zh) * | 2016-11-10 | 2018-05-25 | 上海西浦医药科技有限公司 | 一种索非布韦中间体的合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013173672A1 (en) * | 2012-05-18 | 2013-11-21 | Array Biopharma Inc. | Method for the preparation of thiadiazoles |
-
2014
- 2014-12-30 CN CN201410844333.2A patent/CN104788419B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013173672A1 (en) * | 2012-05-18 | 2013-11-21 | Array Biopharma Inc. | Method for the preparation of thiadiazoles |
Non-Patent Citations (3)
Title |
---|
VON GERHARD KOSZMEHL ET AL.: "Die Wittig-Reaktion von Triphenyl-alkylen-phosphoranen mit Natrium-α-hydroxysulfonaten", 《ANGEW. CHEM.》 * |
刘海军等: "Wittig反应研究进展", 《山西化工》 * |
胡琦艳等: "S-甘油醛缩丙酮的合成及其Wittig反应", 《化学研究》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108069933A (zh) * | 2016-11-10 | 2018-05-25 | 上海西浦医药科技有限公司 | 一种索非布韦中间体的合成方法 |
CN108069933B (zh) * | 2016-11-10 | 2020-06-02 | 上海西浦医药科技有限公司 | 一种索非布韦中间体的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104788419B (zh) | 2018-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Martin et al. | Sulfuranes. 22. Stereochemical course of an associative displacement at tetracoordinate sulfur (IV) in a sulfurane of known absolute configuration. A proposed system of nomenclature for optically active pentacoordinate species | |
US8247583B2 (en) | 3-ethyloxethane compound having hydroxyl group and method for producing the same | |
CN113481524B (zh) | 一种电化学合成3-三氟甲基香豆素化合物的制备方法 | |
CN107286092B (zh) | 甲氧基苯甲酰胺和重氮酸酯经碳-氢官能化制备异喹啉二酮的方法 | |
CN104788419A (zh) | 手性(2,2-二甲基-1,3二氧环戊烷-4-基)羟基甲磺酸盐及其制备方法和应用 | |
CN107721974A (zh) | 一种六元环单硫代碳酸酯的合成方法 | |
CN105481695A (zh) | 一种制备羧酸酯类化合物的方法 | |
CN105254515A (zh) | 一种氯化琥珀胆碱的制备方法 | |
CN104496940B (zh) | 一种制备bcr‑abl抑制剂中间体的方法 | |
CN107513056A (zh) | 一种含四氢呋喃基团的喹啉类化合物的合成方法 | |
CN104402813B (zh) | 一种索拉非尼的制备方法 | |
CN113173909A (zh) | 一种含硒/碲杂环类化合物及其制备方法和转化方法 | |
CN109912396B (zh) | 一种3-溴-4-氟苯甲醛的合成方法 | |
CN107250097A (zh) | 含氟α‑酮羧酸酯类的实用制造方法 | |
CN105294387B (zh) | 制备氯氟环戊烯同分异构体的方法 | |
CN114540843B (zh) | 一种次磺酰胺化合物的电化学合成方法 | |
CN111018679B (zh) | 一种四氟丙基三氟乙烯醚的合成方法 | |
CN112979693B (zh) | 系列烷基三甲基锡化合物及其制备方法与应用 | |
CN107245023A (zh) | 一种选择性脱氧氟化试剂及方法 | |
US20240182438A1 (en) | Method for preparing electronic-grade ethylene sulfate | |
CN113754616B (zh) | 一种反式-3-苯硫基-γ-内酯的制备方法 | |
CN113493386B (zh) | 一种2-氟环丙胺的高选择性不对称合成新工艺 | |
WO2023001088A1 (en) | Preparation method of 3- (2, 2, 2-trifluoroethyl) pyrrolidine hydrochloride | |
CN107892663B (zh) | 一种3,3,4,4-四氟吡咯烷的合成方法 | |
CN106928123A (zh) | 一种特拉匹韦中间体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200701 Address after: 644000 Luolong street, Nanxi District, Yibin City, Sichuan Province Patentee after: Yibin Nanxi Hongguang Pharmaceutical Co.,Ltd. Address before: 610000, No. 999, Jin Zhou road, Jinniu District, Sichuan, Chengdu Patentee before: XIHUA University |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20150722 Assignee: CHENGDU MIRACLE PHARMACEUTICAL Co.,Ltd. Assignor: Yibin Nanxi Hongguang Pharmaceutical Co.,Ltd. Contract record no.: X2021510000026 Denomination of invention: Chiral (2,2-dimethyl-1,3 dioxolane-4-yl) hydroxymethanesulfonate and its preparation method and Application Granted publication date: 20181221 License type: Common License Record date: 20210722 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: CHENGDU MIRACLE PHARMACEUTICAL CO.,LTD. Assignor: Yibin Nanxi Hongguang Pharmaceutical Co.,Ltd. Contract record no.: X2021510000026 Date of cancellation: 20220119 |
|
EC01 | Cancellation of recordation of patent licensing contract |